News
Four new articles from the NIH Technology Transfer Community have been published in the most recent edition of les Nouvelles, the Licensing Executive Society’s journal. NIH is not just a funder of science but is a critical catalyst that helps transform bold ideas into treatments that reach patients
Sharing U.S. Government COVID-19 vaccine-related intellectual property and research tools for greater global access. Through the National Institutes of Health (NIH), the United States has recently licensed the intellectual property and research tools for several COVID-19 technologies to the
The 15 th Annual Philip S. Chen Distinguished Lecture on Innovation and Technology Transfer was held on April 26 th, 2022. This year’s lecture was given by Dr. Peter Basser, Senior Investigator in the Quantitative Imaging and Tissue Science Section at NICHD. Dr. Basser is widely known for the
Join the National Cancer Institute (NCI) for a webinar on an exciting new software platform for providing both a database of target genes modulated by cytokines and a predictive model of cytokine signaling cascades from transcriptomic profiles. “CytoSig” is tool for leveraging the big data resource